Updates

Knowledge Center

HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the Annual Scientific Sessions of the American Heart Association 2024

Innovative AI-enabled research studies led by HeartLung’s founder Dr. Morteza Naghavi show life-saving potential for primary prevention...

HeartLung Technologies Receives FDA “Breakthrough” Designation and Marketing Authorization for AutoChamber™

The First AI that Enables Opportunistic Detection of Hidden Heart Disease in Millions of CT Scans SUMMARY: HeartLung Technologies (...

Dr. Claudia Henschke receives esteemed Joseph W. Cullen Prevention/Early Detection Award at #WCLC2024!

Thrilled to share some fantastic news! 🎉 HeartLung collaborator, Dr. Claudia Henschke, has been recognized with the esteemed Joseph W....

Seven Groundbreaking AI-Enabled Research Studies to be Presented at the Annual Congress of the European Society of Cardiology 2024 in London

Pioneering research by Dr. Naghavi's team from American Heart Technologies and HeartLung.AI highlights AI's transformative impact on...